Skip to main content

Table 1 Characteristics of the study population and biomarker levels

From: Salivary uric acid as a noninvasive biomarker of metabolic syndrome

  Total
(n=78)
Without Metabolic Syndrome (n=51) With Metabolic Syndrome(n=27) p
Age 43.5±1.8 38.0±15.5 53.7±10.2 .000
Gender (male/female) 27/51 17/34 10/17 .745
History of periodontal disease (%) 21.8% 13.7% 37.0% .018
BMI* 26.3±1.2 24.5±1.2 31.6±1.1 .000
Waist Circumference (cm) 91.5±14.3 84.9±10.6 103.9±11.9 .000
Triglycerides (mg/dL)* 97.7±1.8 79.4±1.5 147.9±2.0 .000
HDL(mg/dL)* 45.7±1.4 50.1±1.3 37.2±1.3 .000
Total Cholesterol (mg/dL) 189.1±41.1 176.9±34.3 212.1±43.5 .000
Glucose (mg/dL) 91.3±10.1 88.6±8.0 96.4±11.8 .001
Systolic BP (mmHg) 120.2±13.6 114.8±11.1 130.4±12.3 .000
Diastolic BP (mmHg) 78.5±10.3 74.4±7.2 86.1±11.1 .000
Salivary Uric Acid (M) 217.2±110.3 184.9±78.4 278.1±135.3 .002
Salivary flow rate (mL/min)* 0.46±0.72 0.48±0.47 0.43±0.53 .468
  1. Values are means+ SD.
  2. * P values obtained after log10 transformation. Geometric means are shown